Latest News
Sanofi
- Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
- Exclusive: Sanofi taps new startup ScionxBio for long-acting RNA
- Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine
- Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine
- UPC Court of Appeal hears Sanofi’s challenge over cabazitaxel patent revocation
- Certain insulin pens and cartridges recalled by Sanofi-Aventis Canada Inc.
- Sanofi bets up to $8 Bn on Regeneron’s Immunology pipeline in search for Dupixent successor
- Sanofi and Regeneron expand alliance with $8bn immunology deal
- A New Chapter for the Regeneron-Sanofi Alliance:
- Regeneron and Sanofi Expand Antibody Alliance with Four New Drugs
- Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D
- Regeneron, Sanofi expand alliance with $1 billion upfront deal By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →